Cumberland Pharmaceuticals To Present At The UBS Global Healthcare Conference In New York
May 15, 2013
|
|
|
 |
|
NASHVILLE, Tenn., May 15, 2013 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that it will present a corporate overview at the UBS Global Healthcare Conference at the Sheraton New York hotel on Monday, May 20, 2013, at 9:...
|
|
Message From CEO
May 6, 2013
|
|
|
|
Cumberland Pharmaceuticals Reports First Quarter Financial Results
May 2, 2013
|
|
|
|
|
NASHVILLE, Tenn., May 2, 2013 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today announced first quarter 2013 financial results.
Net Revenue: For the three months ended March 31, 2013, net revenue was $10.3 million, in line with net re...
|
|
Cumberland Pharmaceuticals To Announce First Quarter 2013 Financial Results On May 2, 2013
Apr 25, 2013
|
|
|
|
|
NASHVILLE, Tenn., April 25, 2013 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced today that it will release its first quarter 2013 results after the market closes on Thursday, May 2, 2013. A conference call and live Internet webcast will be held on Thursday, May 2, 2013, at 4:30 p.m. Eastern Time to discuss the results.
...
|
|
Second Acetadote Patent Issued
Apr 10, 2013
|
|
|
|
Cumberland Pharmaceuticals Reports 2012 Annual Financial Results
Feb 28, 2013
|
|
|
|
|
NASHVILLE, Tenn., Feb. 28, 2013 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today announced fourth quarter and annual 2012 financial results.
Net Revenue: For the three months ended December 31, 2012, net revenue was $13.7 million, up...
|
|
Cumberland Pharmaceuticals Licenses Caldolor® (ibuprofen) Injection To Sandor Medicaids Pvt. Ltd. For Commercialization In India
Feb 21, 2013
|
|
|
|
|
NASHVILLE, Tenn., Feb. 21, 2013 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) today announced that it has entered into an exclusive agreement with Sandor Medicaids Pvt. Ltd., an India-based pharmaceutical company, for the commercialization of Caldolor® (ibuprofen) Injection in India.
Under the terms of the agreement, S...
|
|
Caldolor® Reduces Pain And Fever In Adult Patients
Feb 19, 2013
|
|
|
|
|
NASHVILLE, Tenn., Feb. 19, 2013 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) today announced top-line results from two registry studies evaluating the safety and efficacy of Caldolor® (ibuprofen) Injection administered over a shortened infusion time in treating pain and fever in adult patients. The studies involved 450 patien...
|
|
|
|
